Below, Program Director Heather King highlights key items on this year's large and impressive agenda, including sessions on AMP, 340B, the post-AWP world, healthcare reform, and much more. The event is already more than 75% full, so be sure to register soon because the event will probably sell out.
Don’t forget IIR is offering a special 25% discount to Drug Channels readers—up to $850 in savings off the standard rate. Register with VIP code: XP1758DRJL. Thanks, IIR!
OFFICIAL DESCRIPTION FROM IIR
The 17th Annual Medicaid Drug Rebate Program Summit is not just about the MDRP program. It dives deeply into issues with 340B, Medicare Part D, VA and TRICARE.
But it’s called the Medicaid Drug Rebate Program for a reason.
It is the largest, longest running, and most respected event in the MDRP space for the same reason. And that reason is that this event attracts the most industry, state and federal government professionals working in Medicaid rebates than any other event. They provide you unparalleled access to the government regulators creating the rules and the pharmaceutical executives implementing them so you have the most current updates and industry practices to navigate regulatory hurdles and optimize your budget.
In addition to our annual updates on CMS Policy and Operations, we have a full two-day track on MDRP challenges. Highlights include:
- Post-AWP: Impact on Manufacturers of Multiple Mechanisms for State Reimbursement
- Clarify Current Medicaid Rebate Methodology During the Final Rule Waiting Period
- Effect of Acquisitions and Divestiture on MDRP Operations for Pharmaceutical Manufacturers
- Develop a Pricing Committee to Manage Government Program Risks
- MDRP in 2014: How is the Industry Preparing
Don’t forget you can receive 25% off the standard registration rate with Drug Channel’s Priority Code XP1758DRJL. Register online, call (888) 670-8200, or email register@iirusa.com. This event will sell out so be sure to reserve your seat early.
I look forward to welcoming you in Chicago this fall!
Heather King, Program Director
No comments:
Post a Comment